About VARELAS S.A. 

Founded in the early '50s as N.D. VARELAS S.A. Pharmaceuticals & Chemicals,  VARELAS S.A. shifted its focus to the in vitro Diagnostics market in 1978. Renamed VARELAS S.A. Chemicals & Diagnostics in 1993, it later expanded into the Life Science Market in 1997. Today, VARELAS S.A. is a leading supplier to both Public and Private Diagnostic and Life-science Research Laboratories. Pioneering Total Quality Management, it obtained ISO 9002 certification in 2001, and its Quality Management System is presently ISO 9001:2008 and ISO 13485:2003 certified. With 25 highly skilled personnel, the company attributes its success to its commitment to quality. For more information, please visit the varelas.gr.

MGI Tech Co., Ltd. (MGI) is committed to building core tools and technology to lead life science through intelligent innovation. Based on its proprietary technology, MGI focuses on research & development, production, and sales of sequencing instruments***, reagents***, and related products to support life science research, agriculture, precision medicine, and healthcare. MGI's mission is to develop and promote advanced life science tools for future healthcare. As of December 2021, MGI has a footprint that spans across more than 80 countries and regions, serves over 1,300 international users, and employs more than 2,050 professionals globally, around 35% of which are R&D personnel. For more information, please visit the mgi-tech.eu or connect on Twitter, LinkedIn, or YouTube.